Cite
MLA Citation
Naval Daver et al.. “Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia.” Journal of clinical oncology, vol. 40, no. 35, 2022, pp. 4048–4059. http://access.bl.uk/ark:/81055/vdc_100172113466.0x000018